← Back![Pioneering Clinical Research Inc. Logo](/_next/image?url=https%3A%2F%2Fmedicalalley.org%2Fwp-content%2Fuploads%2F2023%2F01%2FBlank.png&w=1080&q=75)
![Pioneering Clinical Research Inc. Logo](/_next/image?url=https%3A%2F%2Fmedicalalley.org%2Fwp-content%2Fuploads%2F2023%2F01%2FBlank.png&w=1080&q=75)
Partner
Pharmaceuticals
About this partner
Pioneering Clinical Technologies (PCT) is a pharmaceutical research & development company that aims to bring to market a novel treatment option for patients with Peripheral Artery Disease (PAD). This novel treatment, Cenderitide (CD-NP), is a synthetic natriuretic peptide, administered using a custom designed subcutaneous infusion pump. Cenderitide is expected to significantly increase walking duration and the quality of life of patients with PAD.